Penserra Capital Management LLC Takes Position in Oscar Health, Inc. (NYSE:OSCR)

Penserra Capital Management LLC acquired a new position in shares of Oscar Health, Inc. (NYSE:OSCR) during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 106,193 shares of the company’s stock, valued at approximately $2,252,000.

A number of other institutional investors also recently bought and sold shares of the business. Vanguard Group Inc. boosted its stake in shares of Oscar Health by 2.4% during the first quarter. Vanguard Group Inc. now owns 14,582,762 shares of the company’s stock worth $216,846,000 after buying an additional 337,850 shares during the period. Price T Rowe Associates Inc. MD grew its stake in shares of Oscar Health by 153.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock valued at $59,156,000 after purchasing an additional 2,409,160 shares during the last quarter. Renaissance Technologies LLC increased its holdings in shares of Oscar Health by 31.7% in the second quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company’s stock valued at $61,478,000 after purchasing an additional 934,600 shares during the period. Assenagon Asset Management S.A. raised its stake in shares of Oscar Health by 32.9% during the second quarter. Assenagon Asset Management S.A. now owns 2,046,046 shares of the company’s stock worth $32,368,000 after purchasing an additional 507,009 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of Oscar Health by 20.3% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,600,166 shares of the company’s stock worth $33,940,000 after purchasing an additional 270,223 shares during the period. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on OSCR. Piper Sandler reissued an “overweight” rating and issued a $28.00 price objective on shares of Oscar Health in a research note on Tuesday, September 10th. UBS Group started coverage on Oscar Health in a research note on Monday, October 7th. They set a “neutral” rating and a $23.00 price target on the stock. Finally, Bank of America downgraded Oscar Health from a “neutral” rating to an “underperform” rating and decreased their target price for the stock from $21.00 to $13.50 in a research report on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, two have given a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Oscar Health currently has an average rating of “Moderate Buy” and an average price target of $22.93.

Insider Activity

In related news, Vice Chairman Joshua Kushner purchased 276,040 shares of the stock in a transaction that occurred on Monday, November 11th. The stock was purchased at an average cost of $13.58 per share, for a total transaction of $3,748,623.20. Following the acquisition, the insider now owns 5,031,262 shares in the company, valued at approximately $68,324,537.96. This trade represents a 5.80 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Mario Schlosser sold 3,198 shares of the business’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total value of $57,532.02. Following the transaction, the insider now owns 76,982 shares in the company, valued at approximately $1,384,906.18. This represents a 3.99 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have bought 1,055,478 shares of company stock valued at $14,432,852 and have sold 194,569 shares valued at $3,433,319. Corporate insiders own 25.11% of the company’s stock.

Oscar Health Stock Up 5.5 %

OSCR opened at $16.86 on Tuesday. The firm has a market cap of $4.17 billion, a P/E ratio of -280.95 and a beta of 1.67. The business’s fifty day simple moving average is $17.80 and its 200 day simple moving average is $18.15. Oscar Health, Inc. has a 52 week low of $7.29 and a 52 week high of $23.79. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.26.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.20) by ($0.02). Oscar Health had a return on equity of 2.79% and a net margin of 0.35%. The business had revenue of $2.42 billion for the quarter, compared to analysts’ expectations of $2.33 billion. During the same period in the prior year, the company earned ($0.29) EPS. The company’s revenue for the quarter was up 68.3% compared to the same quarter last year. As a group, equities research analysts anticipate that Oscar Health, Inc. will post -0.01 EPS for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.